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Background
Left ventricular hypertrophy (LVH) after heart transplant
(HTx) is multifactorial, associations include hypertension,
chronic immune injury and the intrinsic effects of immu-
nosuppression. Its consequences are significant and poten-
tially provide an explanation for the development of
diastolic dysfunction and exercise intolerance, as well as
the limited life expectancy after HTx. Both expansion of
myocardial extracellular volume (ECV) and myocyte
hypertrophy (MH) coexist in this setting. Cardiac biopsies
have limitations and may be non-representative to assess
global myocardial remodeling. The goal of this pilot study
was to characterize both ECV and MH by CMR in cohort
of HTx recipients without active rejection.
Methods
T1 relaxation times were measured before and after gado-
linium contrast. The intracellular lifetime of water (τic), a
cell size-dependent parameter, and extracellular volume
fraction, a marker of interstitial fibrosis, were determined
with a model for transcytolemmal water exchange.
Results
Nineteen HTx recipients (mean age 50±0, 6 female, BSA
1,70±0,16m2, median follow-up after HTx 11±13
months) without acute rejection and 20 age matched
health volunteers (mean age 51±14) underwent CMR
(1.5T) includingmeasurement of LV function, T2, T1
mapping pre- and post-gadolinium and LGE, and a
echocardiogram for measurement of diastolic function.
HTx recipients demonstrated normal LVEF (68±11%)
with a significant increased in LVMass in comparison
with age-matched volunteers (LVMass 114±19g vs.
80±5g; p<0.05). Both groups (HTx and controls) did not
show LGE or abnormal signal intensity in T2 images.
ECV was substantially higher in HTx patients (0,43
±0,14) compared with volunteers (0.29±0.03, p<0.0001).
Both ECV, a marker of interstitial fibrosis, and τic, a
new validated maker of myocyte hypertrophy, were sig-
nificantly associated with LV mass (r=0.72 and r=0.68
respectively , both p<0.05). ECV and τic also demon-
strated a strong association with E wave deceleration
time (EDT) by TTE (r=0.77 and 0.74 respectively, both
p<0.05). ECV maintained the positive association with
EDT indexed to E wave. (r=0.66, p<0.01). by ROC curve
analysis, the ECV was able to predict diastolic dysfunc-
tion using EDT by ETT with AUC 0.97 (ECV cut value
0.37, Sens 100%, Spec 86%, p<0.01).
Conclusions
By CMR, the ECV quantification characterized expan-
sion of extracellular volume in HTx recipients with
increased LV Mass and normal LVEF. Both ECV and τic
were associated with markers of diastolic of dysfunction1Medicine, State University of Campinas - UNICAMP, Campinas, Brazil
Full list of author information is available at the end of the article
Coelho-Filho et al. Journal of Cardiovascular Magnetic
Resonance 2015, 17(Suppl 1):O75
http://www.jcmr-online.com/content/17/S1/O75
© 2015 Coelho-Filho et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
after HTx. Non invasive assessment of ECV and Tau by
CMR may be useful to follow HTx recipients.
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